1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Vaginitis Drug Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Rx 1.2.3 OTC 1.3 Market by Application 1.3.1 Global Vaginitis Drug Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Bacterial Vaginosis 1.3.3 Vulvovaginal Candidasis 1.3.4 Gonorrhea 1.3.5 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Vaginitis Drug Market Perspective (2016-2027) 2.2 Vaginitis Drug Growth Trends by Regions 2.2.1 Vaginitis Drug Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Vaginitis Drug Historic Market Share by Regions (2016-2021) 2.2.3 Vaginitis Drug Forecasted Market Size by Regions (2022-2027) 2.3 Vaginitis Drug Industry Dynamic 2.3.1 Vaginitis Drug Market Trends 2.3.2 Vaginitis Drug Market Drivers 2.3.3 Vaginitis Drug Market Challenges 2.3.4 Vaginitis Drug Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Vaginitis Drug Players by Revenue 3.1.1 Global Top Vaginitis Drug Players by Revenue (2016-2021) 3.1.2 Global Vaginitis Drug Revenue Market Share by Players (2016-2021) 3.2 Global Vaginitis Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Vaginitis Drug Revenue 3.4 Global Vaginitis Drug Market Concentration Ratio 3.4.1 Global Vaginitis Drug Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Vaginitis Drug Revenue in 2020 3.5 Vaginitis Drug Key Players Head office and Area Served 3.6 Key Players Vaginitis Drug Product Solution and Service 3.7 Date of Enter into Vaginitis Drug Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Vaginitis Drug Breakdown Data by Type 4.1 Global Vaginitis Drug Historic Market Size by Type (2016-2021) 4.2 Global Vaginitis Drug Forecasted Market Size by Type (2022-2027) 5 Vaginitis Drug Breakdown Data by Application 5.1 Global Vaginitis Drug Historic Market Size by Application (2016-2021) 5.2 Global Vaginitis Drug Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Vaginitis Drug Market Size (2016-2027) 6.2 North America Vaginitis Drug Market Size by Type 6.2.1 North America Vaginitis Drug Market Size by Type (2016-2021) 6.2.2 North America Vaginitis Drug Market Size by Type (2022-2027) 6.2.3 North America Vaginitis Drug Market Size by Type (2016-2027) 6.3 North America Vaginitis Drug Market Size by Application 6.3.1 North America Vaginitis Drug Market Size by Application (2016-2021) 6.3.2 North America Vaginitis Drug Market Size by Application (2022-2027) 6.3.3 North America Vaginitis Drug Market Size by Application (2016-2027) 6.4 North America Vaginitis Drug Market Size by Country 6.4.1 North America Vaginitis Drug Market Size by Country (2016-2021) 6.4.2 North America Vaginitis Drug Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Vaginitis Drug Market Size (2016-2027) 7.2 Europe Vaginitis Drug Market Size by Type 7.2.1 Europe Vaginitis Drug Market Size by Type (2016-2021) 7.2.2 Europe Vaginitis Drug Market Size by Type (2022-2027) 7.2.3 Europe Vaginitis Drug Market Size by Type (2016-2027) 7.3 Europe Vaginitis Drug Market Size by Application 7.3.1 Europe Vaginitis Drug Market Size by Application (2016-2021) 7.3.2 Europe Vaginitis Drug Market Size by Application (2022-2027) 7.3.3 Europe Vaginitis Drug Market Size by Application (2016-2027) 7.4 Europe Vaginitis Drug Market Size by Country 7.4.1 Europe Vaginitis Drug Market Size by Country (2016-2021) 7.4.2 Europe Vaginitis Drug Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Vaginitis Drug Market Size (2016-2027) 8.2 Asia-Pacific Vaginitis Drug Market Size by Type 8.2.1 Asia-Pacific Vaginitis Drug Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Vaginitis Drug Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Vaginitis Drug Market Size by Type (2016-2027) 8.3 Asia-Pacific Vaginitis Drug Market Size by Application 8.3.1 Asia-Pacific Vaginitis Drug Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Vaginitis Drug Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Vaginitis Drug Market Size by Application (2016-2027) 8.4 Asia-Pacific Vaginitis Drug Market Size by Region 8.4.1 Asia-Pacific Vaginitis Drug Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Vaginitis Drug Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Vaginitis Drug Market Size (2016-2027) 9.2 Latin America Vaginitis Drug Market Size by Type 9.2.1 Latin America Vaginitis Drug Market Size by Type (2016-2021) 9.2.2 Latin America Vaginitis Drug Market Size by Type (2022-2027) 9.2.3 Latin America Vaginitis Drug Market Size by Type (2016-2027) 9.3 Latin America Vaginitis Drug Market Size by Application 9.3.1 Latin America Vaginitis Drug Market Size by Application (2016-2021) 9.3.2 Latin America Vaginitis Drug Market Size by Application (2022-2027) 9.3.3 Latin America Vaginitis Drug Market Size by Application (2016-2027) 9.4 Latin America Vaginitis Drug Market Size by Country 9.4.1 Latin America Vaginitis Drug Market Size by Country (2016-2021) 9.4.2 Latin America Vaginitis Drug Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Vaginitis Drug Market Size (2016-2027) 10.2 Middle East & Africa Vaginitis Drug Market Size by Type 10.2.1 Middle East & Africa Vaginitis Drug Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Vaginitis Drug Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Vaginitis Drug Market Size by Type (2016-2027) 10.3 Middle East & Africa Vaginitis Drug Market Size by Application 10.3.1 Middle East & Africa Vaginitis Drug Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Vaginitis Drug Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Vaginitis Drug Market Size by Application (2016-2027) 10.4 Middle East & Africa Vaginitis Drug Market Size by Country 10.4.1 Middle East & Africa Vaginitis Drug Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Vaginitis Drug Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Bayer 11.1.1 Bayer Company Details 11.1.2 Bayer Business Overview 11.1.3 Bayer Vaginitis Drug Introduction 11.1.4 Bayer Revenue in Vaginitis Drug Business (2016-2021) 11.1.5 Bayer Recent Development 11.2 Pfizer 11.2.1 Pfizer Company Details 11.2.2 Pfizer Business Overview 11.2.3 Pfizer Vaginitis Drug Introduction 11.2.4 Pfizer Revenue in Vaginitis Drug Business (2016-2021) 11.2.5 Pfizer Recent Development 11.3 Sanofi 11.3.1 Sanofi Company Details 11.3.2 Sanofi Business Overview 11.3.3 Sanofi Vaginitis Drug Introduction 11.3.4 Sanofi Revenue in Vaginitis Drug Business (2016-2021) 11.3.5 Sanofi Recent Development 11.4 Piramal 11.4.1 Piramal Company Details 11.4.2 Piramal Business Overview 11.4.3 Piramal Vaginitis Drug Introduction 11.4.4 Piramal Revenue in Vaginitis Drug Business (2016-2021) 11.4.5 Piramal Recent Development 11.5 Abbott 11.5.1 Abbott Company Details 11.5.2 Abbott Business Overview 11.5.3 Abbott Vaginitis Drug Introduction 11.5.4 Abbott Revenue in Vaginitis Drug Business (2016-2021) 11.5.5 Abbott Recent Development 11.6 Galderma 11.6.1 Galderma Company Details 11.6.2 Galderma Business Overview 11.6.3 Galderma Vaginitis Drug Introduction 11.6.4 Galderma Revenue in Vaginitis Drug Business (2016-2021) 11.6.5 Galderma Recent Development 11.7 Mission 11.7.1 Mission Company Details 11.7.2 Mission Business Overview 11.7.3 Mission Vaginitis Drug Introduction 11.7.4 Mission Revenue in Vaginitis Drug Business (2016-2021) 11.7.5 Mission Recent Development 11.8 Alkem 11.8.1 Alkem Company Details 11.8.2 Alkem Business Overview 11.8.3 Alkem Vaginitis Drug Introduction 11.8.4 Alkem Revenue in Vaginitis Drug Business (2016-2021) 11.8.5 Alkem Recent Development 11.9 Xiuzheng 11.9.1 Xiuzheng Company Details 11.9.2 Xiuzheng Business Overview 11.9.3 Xiuzheng Vaginitis Drug Introduction 11.9.4 Xiuzheng Revenue in Vaginitis Drug Business (2016-2021) 11.9.5 Xiuzheng Recent Development 11.10 Teva 11.10.1 Teva Company Details 11.10.2 Teva Business Overview 11.10.3 Teva Vaginitis Drug Introduction 11.10.4 Teva Revenue in Vaginitis Drug Business (2016-2021) 11.10.5 Teva Recent Development 11.11 Perrigo 11.11.1 Perrigo Company Details 11.11.2 Perrigo Business Overview 11.11.3 Perrigo Vaginitis Drug Introduction 11.11.4 Perrigo Revenue in Vaginitis Drug Business (2016-2021) 11.11.5 Perrigo Recent Development 11.12 West-Ward 11.12.1 West-Ward Company Details 11.12.2 West-Ward Business Overview 11.12.3 West-Ward Vaginitis Drug Introduction 11.12.4 West-Ward Revenue in Vaginitis Drug Business (2016-2021) 11.12.5 West-Ward Recent Development 11.13 HPGC 11.13.1 HPGC Company Details 11.13.2 HPGC Business Overview 11.13.3 HPGC Vaginitis Drug Introduction 11.13.4 HPGC Revenue in Vaginitis Drug Business (2016-2021) 11.13.5 HPGC Recent Development 11.14 Yunnan Baiyao 11.14.1 Yunnan Baiyao Company Details 11.14.2 Yunnan Baiyao Business Overview 11.14.3 Yunnan Baiyao Vaginitis Drug Introduction 11.14.4 Yunnan Baiyao Revenue in Vaginitis Drug Business (2016-2021) 11.14.5 Yunnan Baiyao Recent Development 11.15 Starpharma 11.15.1 Starpharma Company Details 11.15.2 Starpharma Business Overview 11.15.3 Starpharma Vaginitis Drug Introduction 11.15.4 Starpharma Revenue in Vaginitis Drug Business (2016-2021) 11.15.5 Starpharma Recent Development 11.16 Novel 11.16.1 Novel Company Details 11.16.2 Novel Business Overview 11.16.3 Novel Vaginitis Drug Introduction 11.16.4 Novel Revenue in Vaginitis Drug Business (2016-2021) 11.16.5 Novel Recent Development 11.17 Edenvridge 11.17.1 Edenvridge Company Details 11.17.2 Edenvridge Business Overview 11.17.3 Edenvridge Vaginitis Drug Introduction 11.17.4 Edenvridge Revenue in Vaginitis Drug Business (2016-2021) 11.17.5 Edenvridge Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Vaginitis Drug Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Rx Table 3. Key Players of OTC Table 4. Global Vaginitis Drug Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 5. Global Vaginitis Drug Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global Vaginitis Drug Market Size by Regions (2016-2021) & (US$ Million) Table 7. Global Vaginitis Drug Market Share by Regions (2016-2021) Table 8. Global Vaginitis Drug Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 9. Global Vaginitis Drug Market Share by Regions (2022-2027) Table 10. Vaginitis Drug Market Trends Table 11. Vaginitis Drug Market Drivers Table 12. Vaginitis Drug Market Challenges Table 13. Vaginitis Drug Market Restraints Table 14. Global Vaginitis Drug Revenue by Players (2016-2021) & (US$ Million) Table 15. Global Vaginitis Drug Market Share by Players (2016-2021) Table 16. Global Top Vaginitis Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Vaginitis Drug as of 2020) Table 17. Ranking of Global Top Vaginitis Drug Companies by Revenue (US$ Million) in 2020 Table 18. Global 5 Largest Players Market Share by Vaginitis Drug Revenue (CR5 and HHI) & (2016-2021) Table 19. Key Players Headquarters and Area Served Table 20. Key Players Vaginitis Drug Product Solution and Service Table 21. Date of Enter into Vaginitis Drug Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global Vaginitis Drug Market Size by Type (2016-2021) (US$ Million) Table 24. Global Vaginitis Drug Revenue Market Share by Type (2016-2021) Table 25. Global Vaginitis Drug Forecasted Market Size by Type (2022-2027) (US$ Million) Table 26. Global Vaginitis Drug Revenue Market Share by Type (2022-2027) & (US$ Million) Table 27. Global Vaginitis Drug Market Size Share by Application (2016-2021) & (US$ Million) Table 28. Global Vaginitis Drug Revenue Market Share by Application (2016-2021) Table 29. Global Vaginitis Drug Forecasted Market Size by Application (2022-2027) (US$ Million) Table 30. Global Vaginitis Drug Revenue Market Share by Application (2022-2027) & (US$ Million) Table 31. North America Vaginitis Drug Market Size by Type (2016-2021) (US$ Million) Table 32. North America Vaginitis Drug Market Size by Type (2022-2027) & (US$ Million) Table 33. North America Vaginitis Drug Market Size by Application (2016-2021) (US$ Million) Table 34. North America Vaginitis Drug Market Size by Application (2022-2027) & (US$ Million) Table 35. North America Vaginitis Drug Market Size by Country (2016-2021) & (US$ Million) Table 36. North America Vaginitis Drug Market Size by Country (2022-2027) & (US$ Million) Table 37. Europe Vaginitis Drug Market Size by Type (2016-2021) (US$ Million) Table 38. Europe Vaginitis Drug Market Size by Type (2022-2027) & (US$ Million) Table 39. Europe Vaginitis Drug Market Size by Application (2016-2021) (US$ Million) Table 40. Europe Vaginitis Drug Market Size by Application (2022-2027) & (US$ Million) Table 41. Europe Vaginitis Drug Market Size by Country (2016-2021) & (US$ Million) Table 42. Europe Vaginitis Drug Market Size by Country (2022-2027) & (US$ Million) Table 43. Asia-Pacific Vaginitis Drug Market Size by Type (2016-2021) (US$ Million) Table 44. Asia-Pacific Vaginitis Drug Market Size by Type (2022-2027) & (US$ Million) Table 45. Asia-Pacific Vaginitis Drug Market Size by Application (2016-2021) (US$ Million) Table 46. Asia-Pacific Vaginitis Drug Market Size by Application (2022-2027) & (US$ Million) Table 47. Asia-Pacific Vaginitis Drug Market Size by Region (2016-2021) & (US$ Million) Table 48. Asia-Pacific Vaginitis Drug Market Size by Region (2022-2027) & (US$ Million) Table 49. Latin America Vaginitis Drug Market Size by Type (2016-2021) (US$ Million) Table 50. Latin America Vaginitis Drug Market Size by Type (2022-2027) & (US$ Million) Table 51. Latin America Vaginitis Drug Market Size by Application (2016-2021) (US$ Million) Table 52. Latin America Vaginitis Drug Market Size by Application (2022-2027) & (US$ Million) Table 53. Latin America Vaginitis Drug Market Size by Country (2016-2021) & (US$ Million) Table 54. Latin America Vaginitis Drug Market Size by Country (2022-2027) & (US$ Million) Table 55. Middle East & Africa Vaginitis Drug Market Size by Type (2016-2021) (US$ Million) Table 56. Middle East & Africa Vaginitis Drug Market Size by Type (2022-2027) & (US$ Million) Table 57. Middle East & Africa Vaginitis Drug Market Size by Application (2016-2021) (US$ Million) Table 58. Middle East & Africa Vaginitis Drug Market Size by Application (2022-2027) & (US$ Million) Table 59. Middle East & Africa Vaginitis Drug Market Size by Country (2016-2021) & (US$ Million) Table 60. Middle East & Africa Vaginitis Drug Market Size by Country (2022-2027) & (US$ Million) Table 61. Bayer Company Details Table 62. Bayer Business Overview Table 63. Bayer Vaginitis Drug Product Table 64. Bayer Revenue in Vaginitis Drug Business (2016-2021) & (US$ Million) Table 65. Bayer Recent Development Table 66. Pfizer Company Details Table 67. Pfizer Business Overview Table 68. Pfizer Vaginitis Drug Product Table 69. Pfizer Revenue in Vaginitis Drug Business (2016-2021) & (US$ Million) Table 70. Pfizer Recent Development Table 71. Sanofi Company Details Table 72. Sanofi Business Overview Table 73. Sanofi Vaginitis Drug Product Table 74. Sanofi Revenue in Vaginitis Drug Business (2016-2021) & (US$ Million) Table 75. Sanofi Recent Development Table 76. Piramal Company Details Table 77. Piramal Business Overview Table 78. Piramal Vaginitis Drug Product Table 79. Piramal Revenue in Vaginitis Drug Business (2016-2021) & (US$ Million) Table 80. Piramal Recent Development Table 81. Abbott Company Details Table 82. Abbott Business Overview Table 83. Abbott Vaginitis Drug Product Table 84. Abbott Revenue in Vaginitis Drug Business (2016-2021) & (US$ Million) Table 85. Abbott Recent Development Table 86. Galderma Company Details Table 87. Galderma Business Overview Table 88. Galderma Vaginitis Drug Product Table 89. Galderma Revenue in Vaginitis Drug Business (2016-2021) & (US$ Million) Table 90. Galderma Recent Development Table 91. Mission Company Details Table 92. Mission Business Overview Table 93. Mission Vaginitis Drug Product Table 94. Mission Revenue in Vaginitis Drug Business (2016-2021) & (US$ Million) Table 95. Mission Recent Development Table 96. Alkem Company Details Table 97. Alkem Business Overview Table 98. Alkem Revenue in Vaginitis Drug Business (2016-2021) & (US$ Million) Table 99. Alkem Recent Development Table 100. Xiuzheng Company Details Table 101. Xiuzheng Business Overview Table 102. Xiuzheng Vaginitis Drug Product Table 103. Xiuzheng Revenue in Vaginitis Drug Business (2016-2021) & (US$ Million) Table 104. Xiuzheng Recent Development Table 105. Teva Company Details Table 106. Teva Business Overview Table 107. Teva Vaginitis Drug Product Table 108. Teva Revenue in Vaginitis Drug Business (2016-2021) & (US$ Million) Table 109. Teva Recent Development Table 110. Perrigo Company Details Table 111. Perrigo Business Overview Table 112. Perrigo Vaginitis Drug Product Table 113. Perrigo Revenue in Vaginitis Drug Business (2016-2021) & (US$ Million) Table 114. Perrigo Recent Development Table 115. West-Ward Company Details Table 116. West-Ward Business Overview Table 117. West-Ward Vaginitis Drug Product Table 118. West-Ward Revenue in Vaginitis Drug Business (2016-2021) & (US$ Million) Table 119. West-Ward Recent Development Table 120. HPGC Company Details Table 121. HPGC Business Overview Table 122. HPGC Vaginitis Drug Product Table 123. HPGC Revenue in Vaginitis Drug Business (2016-2021) & (US$ Million) Table 124. HPGC Recent Development Table 125. Yunnan Baiyao Company Details Table 126. Yunnan Baiyao Business Overview Table 127. Yunnan Baiyao Vaginitis Drug Product Table 128. Yunnan Baiyao Revenue in Vaginitis Drug Business (2016-2021) & (US$ Million) Table 129. Yunnan Baiyao Recent Development Table 130. Starpharma Company Details Table 131. Starpharma Business Overview Table 132. Starpharma Vaginitis Drug Product Table 133. Starpharma Revenue in Vaginitis Drug Business (2016-2021) & (US$ Million) Table 134. Starpharma Recent Development Table 135. Novel Company Details Table 136. Novel Business Overview Table 137. Novel Vaginitis Drug Product Table 138. Novel Revenue in Vaginitis Drug Business (2016-2021) & (US$ Million) Table 139. Novel Recent Development Table 140. Edenvridge Company Details Table 141. Edenvridge Business Overview Table 142. Edenvridge Vaginitis Drug Product Table 143. Edenvridge Revenue in Vaginitis Drug Business (2016-2021) & (US$ Million) Table 144. Edenvridge Recent Development Table 145. Research Programs/Design for This Report Table 146. Key Data Information from Secondary Sources Table 147. Key Data Information from Primary Sources List of Figures Figure 1. Global Vaginitis Drug Market Share by Type: 2020 VS 2027 Figure 2. Rx Features Figure 3. OTC Features Figure 4. Global Vaginitis Drug Market Share by Application: 2020 VS 2027 Figure 5. Bacterial Vaginosis Case Studies Figure 6. Vulvovaginal Candidasis Case Studies Figure 7. Gonorrhea Case Studies Figure 8. Others Case Studies Figure 9. Vaginitis Drug Report Years Considered Figure 10. Global Vaginitis Drug Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 11. Global Vaginitis Drug Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 12. Global Vaginitis Drug Market Share by Regions: 2020 VS 2027 Figure 13. Global Vaginitis Drug Market Share by Regions (2022-2027) Figure 14. Global Vaginitis Drug Market Share by Players in 2020 Figure 15. Global Top Vaginitis Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Vaginitis Drug as of 2020 Figure 16. The Top 10 and 5 Players Market Share by Vaginitis Drug Revenue in 2020 Figure 17. Global Vaginitis Drug Revenue Market Share by Type (2016-2021) Figure 18. Global Vaginitis Drug Revenue Market Share by Type (2022-2027) Figure 19. North America Vaginitis Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 20. North America Vaginitis Drug Market Share by Type (2016-2027) Figure 21. North America Vaginitis Drug Market Share by Application (2016-2027) Figure 22. North America Vaginitis Drug Market Share by Country (2016-2027) Figure 23. United States Vaginitis Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. Canada Vaginitis Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Europe Vaginitis Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Europe Vaginitis Drug Market Share by Type (2016-2027) Figure 27. Europe Vaginitis Drug Market Share by Application (2016-2027) Figure 28. Europe Vaginitis Drug Market Share by Country (2016-2027) Figure 29. Germany Vaginitis Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. France Vaginitis Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. U.K. Vaginitis Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. Italy Vaginitis Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Russia Vaginitis Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Nordic Vaginitis Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Asia-Pacific Vaginitis Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Asia-Pacific Vaginitis Drug Market Share by Type (2016-2027) Figure 37. Asia-Pacific Vaginitis Drug Market Share by Application (2016-2027) Figure 38. Asia-Pacific Vaginitis Drug Market Share by Region (2016-2027) Figure 39. China Vaginitis Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. Japan Vaginitis Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. South Korea Vaginitis Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. Southeast Asia Vaginitis Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. India Vaginitis Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Australia Vaginitis Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Latin America Vaginitis Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Latin America Vaginitis Drug Market Share by Type (2016-2027) Figure 47. Latin America Vaginitis Drug Market Share by Application (2016-2027) Figure 48. Latin America Vaginitis Drug Market Share by Country (2016-2027) Figure 49. Mexico Vaginitis Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Brazil Vaginitis Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Middle East & Africa Vaginitis Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Middle East & Africa Vaginitis Drug Market Share by Type (2016-2027) Figure 53. Middle East & Africa Vaginitis Drug Market Share by Application (2016-2027) Figure 54. Middle East & Africa Vaginitis Drug Market Share by Country (2016-2027) Figure 55. Turkey Vaginitis Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. Saudi Arabia Vaginitis Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. UAE Vaginitis Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. Bayer Revenue Growth Rate in Vaginitis Drug Business (2016-2021) Figure 59. Pfizer Revenue Growth Rate in Vaginitis Drug Business (2016-2021) Figure 60. Sanofi Revenue Growth Rate in Vaginitis Drug Business (2016-2021) Figure 61. Piramal Revenue Growth Rate in Vaginitis Drug Business (2016-2021) Figure 62. Abbott Revenue Growth Rate in Vaginitis Drug Business (2016-2021) Figure 63. Galderma Revenue Growth Rate in Vaginitis Drug Business (2016-2021) Figure 64. Mission Revenue Growth Rate in Vaginitis Drug Business (2016-2021) Figure 65. Alkem Revenue Growth Rate in Vaginitis Drug Business (2016-2021) Figure 66. Xiuzheng Revenue Growth Rate in Vaginitis Drug Business (2016-2021) Figure 67. Teva Revenue Growth Rate in Vaginitis Drug Business (2016-2021) Figure 68. Perrigo Revenue Growth Rate in Vaginitis Drug Business (2016-2021) Figure 69. West-Ward Revenue Growth Rate in Vaginitis Drug Business (2016-2021) Figure 70. HPGC Revenue Growth Rate in Vaginitis Drug Business (2016-2021) Figure 71. Yunnan Baiyao Revenue Growth Rate in Vaginitis Drug Business (2016-2021) Figure 72. Starpharma Revenue Growth Rate in Vaginitis Drug Business (2016-2021) Figure 73. Novel Revenue Growth Rate in Vaginitis Drug Business (2016-2021) Figure 74. Edenvridge Revenue Growth Rate in Vaginitis Drug Business (2016-2021) Figure 75. Bottom-up and Top-down Approaches for This Report Figure 76. Data Triangulation Figure 77. Key Executives Interviewed

Bayer Pfizer Sanofi Piramal Abbott Galderma Mission Alkem Xiuzheng Teva Perrigo West-Ward HPGC Yunnan Baiyao Starpharma Novel Edenvridge